About Thirona
Thirona is a company based in Nijmegen (Netherlands) founded in 2014 was acquired by Revenio Group in August 2024. Thirona has raised $5.37 million across 3 funding rounds from investors including Revenio Group, Heran Partners and Borski Fund. Thirona offers products and services including Thoracic CT Analysis Tool and Drug Development Platform. Thirona operates in a competitive market with competitors including Change Healthcare, AIdoc, HeartFlow, Cleerly and eCential Robotics, among others.
- Headquarter Nijmegen, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.37 M (USD)
in 3 rounds
-
Latest Funding Round
$5.37 M (USD), Series A
Sep 11, 2023
-
Investors
Revenio Group
& 3 more
-
Employee Count
Not available
-
Acquired by
Revenio Group
(Aug 20, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Thirona
Thirona offers a comprehensive portfolio of products and services, including Thoracic CT Analysis Tool and Drug Development Platform.
Analyzes lung images to quantify diseases for clinical diagnostics.
Supports trials with quantitative image analysis for treatment development.
People of Thirona
Unlock access to complete
Unlock access to complete
Funding Insights of Thirona
Thirona has successfully raised a total of $5.37M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5.37 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Thirona
Thirona has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Revenio Group, Heran Partners and Borski Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to healthcare and life sciences innovators.
|
Locked | Locked | Locked | |
|
Venture capital investments are made in diverse, gender-balanced teams.
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for Thirona
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Thirona
Investment portfolio details for Thirona
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Thirona
Detailed financials for Thirona
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thirona Comparisons
Peer comparison for Thirona
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Thirona
Thirona operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Change Healthcare, AIdoc, HeartFlow, Cleerly and eCential Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based solutions are delivered for healthcare payers, providers, and patients.
|
|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Cardiovascular diagnostics are provided using CT scans and analytics.
|
|
| Locked | Locked | Locked |
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
Detailed competitors of Thirona
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thirona
Complete news archive for Thirona
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thirona
Thirona was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Thirona is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.
Thirona is a funded company, having raised a total of $5.37M across 3 funding rounds to date.
Thirona was established in 2014 in Nijmegen, Netherlands, within the healthcare technology sector. AI-driven software for medical image analysis is developed and supplied. Chest CT is utilized for quantifying lung conditions in CT scans, aiding detection and treatment of respiratory diseases. CAD4TB functions as a detection tool for tuberculosis anomalies. RetCAD identifies issues linked to age-related macular degeneration and diabetic retinopathy. Focus is placed on clinical support across imaging modalities.
Thirona's top competitors include Change Healthcare, AIdoc and eCential Robotics.
Thirona offers Thoracic CT Analysis Tool and Drug Development Platform.
Thirona has 4 investors. Key investors include Revenio Group, Heran Partners, Borski Fund, and EIC Fund.